| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |